X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA PIRAMAL ENTERPRISES SHASUN PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 123.9 9.1 1,361.1% View Chart
P/BV x 8.5 3.0 282.8% View Chart
Dividend Yield % 0.2 0.8 28.9%  

Financials

 SHASUN PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
PIRAMAL ENTERPRISES
Mar-17
SHASUN PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs942,095 4.5%   
Low Rs461,025 4.4%   
Sales per share (Unadj.) Rs214.2492.8 43.5%  
Earnings per share (Unadj.) Rs5.372.6 7.4%  
Cash flow per share (Unadj.) Rs15.894.7 16.7%  
Dividends per share (Unadj.) Rs1.0021.00 4.8%  
Dividend yield (eoy) %1.41.3 106.3%  
Book value per share (Unadj.) Rs53.3862.5 6.2%  
Shares outstanding (eoy) m56.62172.56 32.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.2 10.3%   
Avg P/E ratio x13.121.5 60.9%  
P/CF ratio (eoy) x4.416.5 26.8%  
Price / Book Value ratio x1.31.8 72.4%  
Dividend payout %18.728.9 64.8%   
Avg Mkt Cap Rs m3,958269,194 1.5%   
No. of employees `000NA4.0 0.0%   
Total wages/salary Rs m2,16417,939 12.1%   
Avg. sales/employee Rs ThNM21,190.3-  
Avg. wages/employee Rs ThNM4,470.1-  
Avg. net profit/employee Rs ThNM3,120.0-  
INCOME DATA
Net Sales Rs m12,12785,037 14.3%  
Other income Rs m2292,338 9.8%   
Total revenues Rs m12,35687,374 14.1%   
Gross profit Rs m1,00934,991 2.9%  
Depreciation Rs m5943,817 15.6%   
Interest Rs m41520,310 2.0%   
Profit before tax Rs m23013,202 1.7%   
Minority Interest Rs m01,699 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m-732,281 -3.2%   
Profit after tax Rs m30212,520 2.4%  
Gross profit margin %8.341.1 20.2%  
Effective tax rate %-31.717.3 -183.2%   
Net profit margin %2.514.7 16.9%  
BALANCE SHEET DATA
Current assets Rs m6,88487,590 7.9%   
Current liabilities Rs m8,456185,578 4.6%   
Net working cap to sales %-13.0-115.2 11.2%  
Current ratio x0.80.5 172.5%  
Inventory Days Days6231 198.6%  
Debtors Days Days10848 226.2%  
Net fixed assets Rs m4,970108,523 4.6%   
Share capital Rs m113345 32.8%   
"Free" reserves Rs m2,875148,481 1.9%   
Net worth Rs m3,020148,826 2.0%   
Long term debt Rs m1,817144,957 1.3%   
Total assets Rs m13,347482,394 2.8%  
Interest coverage x1.61.7 94.1%   
Debt to equity ratio x0.61.0 61.8%  
Sales to assets ratio x0.90.2 515.4%   
Return on assets %5.46.8 79.0%  
Return on equity %10.08.4 118.9%  
Return on capital %13.312.0 111.5%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84315,001 38.9%   
Fx outflow Rs m2,1735,150 42.2%   
Net fx Rs m3,6699,851 37.2%   
CASH FLOW
From Operations Rs m398-100,393 -0.4%  
From Investments Rs m-1,635-24,202 6.8%  
From Financial Activity Rs m1,309135,705 1.0%  
Net Cashflow Rs m7111,110 0.6%  

Share Holding

Indian Promoters % 39.2 52.9 74.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.0 90.0%  
FIIs % 17.6 26.6 66.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 16.5 240.0%  
Shareholders   20,750 93,274 22.2%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   CIPLA  PFIZER  ALKEM LABORATORIES  SUN PHARMA  SANOFI INDIA  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY18); Net Profit Up 1230.7%

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 39 bn (up 1230.7% YoY). Sales on the other hand came in at Rs 30 bn (up 21.5% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - DISHMAN PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS